The Beauty Health Company (SKIN) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

The Beauty Health Company (SKIN) Consumer Business Overview

The Beauty Health Company (SKIN) designs, develops, and markets aesthetic technologies, highlighted by its flagship HydraFacial system. Operating in the consumer defensive sector, the company focuses on enhancing skin health through cleansing, exfoliation, and hydration, targeting a personalized experience via its Syndeo delivery system and HydraFacial Nation App.

What Is the Investment Thesis for SKIN?

The Beauty Health Company (SKIN) presents a focused investment opportunity within the aesthetic technology sector. The company's core value driver is the continued adoption and expansion of its HydraFacial system, evidenced by a gross margin of 64.9%. Growth catalysts include the ongoing rollout of the Syndeo system and increased user engagement through the HydraFacial Nation App. However, the company's negative profit margin of -2.0% poses a risk, requiring close monitoring of cost management and revenue scaling. The company's beta of 1.24 indicates higher volatility compared to the market. Success hinges on effectively marketing its products, managing operational costs, and capitalizing on the growing demand for non-invasive aesthetic treatments.

Based on FMP financials and quantitative analysis

SKIN Key Highlights

Gross margin of 64.9% indicates strong pricing power and efficient production of HydraFacial and related products.

• Market capitalization of $89.7M reflects the company's current valuation in the aesthetic technology market.
• 769 employees support the company's global operations in developing, manufacturing, and marketing aesthetic technologies.
• HydraFacial system is the flagship product, driving the majority of revenue and brand recognition.
• Absence of dividend yield reflects a focus on reinvesting earnings for growth and product development.

Who Are SKIN's Competitors?

SKIN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SKIN's Key Strengths?

Established brand recognition with HydraFacial.

• Proprietary technology and patented solutions.
• Recurring revenue from consumables.
• Global distribution network.

What Are SKIN's Weaknesses?

Negative profit margin.

• High dependence on HydraFacial system.
• Limited product diversification.
• Small market capitalization.

What Could Drive SKIN Stock Higher?

SKIN catalyst: Continued rollout and adoption of the Syndeo HydraFacial Delivery System, enhancing treatment personalization and customer loyalty.

• Increased user engagement and data collection through the HydraFacial Nation App, driving targeted marketing and product development.
• Potential expansion into new international markets, tapping into growing demand for aesthetic treatments.
• Development and launch of new aesthetic technologies and products, expanding the company's addressable market.

What Are the Key Risks for SKIN?

Listing risk — at $0.6924 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.

• Financial-distress signal — its Altman Z-Score of -0.47 sits in the distress zone (elevated bankruptcy risk).
• Negative return on equity (-47.8%) — the business is not currently generating profit on shareholder capital.
• Negative profit margin, requiring improved cost management and revenue scaling.
• Competition from established aesthetic technology companies, impacting market share and pricing.
• Economic downturn impacting consumer spending on discretionary aesthetic treatments.
• Regulatory changes affecting the aesthetic treatment market, increasing compliance costs and limiting treatment options.

What Are the Growth Opportunities for SKIN?

• Expansion of Syndeo System: The rollout of the Syndeo HydraFacial Delivery System offers a significant growth opportunity. By connecting providers to consumer preferences, Syndeo enhances the treatment experience and fosters customer loyalty. The market for personalized aesthetic treatments is growing, and Syndeo positions Beauty Health to capitalize on this trend. Successful implementation and marketing of Syndeo can drive increased revenue and market share.
• HydraFacial Nation App Engagement: The HydraFacial Nation App provides a platform for engaging consumers, tracking treatments, and promoting skin health education. Increased user engagement can lead to higher treatment frequency and product sales. The app also generates valuable data for personalizing treatments and marketing efforts. By enhancing the app's features and promoting its adoption, Beauty Health can strengthen its customer relationships and drive revenue growth.
• Keravive Scalp Health Treatment: The Keravive treatment for scalp health represents a new growth area for Beauty Health. The market for scalp care products and treatments is expanding, driven by increasing awareness of the importance of scalp health for overall hair health. By effectively marketing Keravive and demonstrating its benefits, Beauty Health can capture a share of this growing market and diversify its revenue streams.
• International Market Expansion: Expanding into new international markets offers a significant growth opportunity. The demand for aesthetic treatments is growing globally, particularly in emerging markets. By adapting its products and marketing strategies to local preferences, Beauty Health can tap into these new markets and drive revenue growth. Successful international expansion requires careful market research and strategic partnerships.
• Product Innovation and Development: Continued innovation and development of new aesthetic technologies and products are crucial for long-term growth. By investing in research and development, Beauty Health can stay ahead of the competition and meet evolving consumer needs. New products can expand the company's addressable market and drive revenue growth. Successful product innovation requires a deep understanding of market trends and consumer preferences.

What Are SKIN's Competitive Advantages?

• Proprietary HydraFacial technology with patented solutions and serums.
• Established brand recognition and reputation in the aesthetic treatment market.
• Recurring revenue stream from consumable products.
• Syndeo system enhances customer loyalty.

What Does SKIN Do?

The Beauty Health Company, founded in 1997 and headquartered in Long Beach, California, specializes in aesthetic technologies and products. Its flagship product, HydraFacial, is a multi-step treatment that cleanses, peels, exfoliates, extracts, infuses, and hydrates the skin using proprietary solutions and serums. The company's product line also includes Syndeo, a HydraFacial Delivery System designed to personalize the treatment experience by connecting providers to consumer preferences. The HydraFacial Nation App allows users to track their skin health and treatment progress. Additionally, Beauty Health offers Keravive, a treatment focused on scalp health. The company markets its products worldwide, targeting spas, medical practices, and beauty professionals. Beauty Health aims to innovate in the aesthetic treatment space by integrating technology and personalized experiences into its offerings. The company's evolution has centered on expanding the applications of HydraFacial technology and creating complementary products to enhance the core treatment's effectiveness and consumer engagement.

What Products and Services Does SKIN Offer?

• Designs and develops aesthetic technologies.
• Manufactures aesthetic treatment systems.
• Markets and sells HydraFacial systems and related products.
• Offers Syndeo, a personalized HydraFacial delivery system.
• Provides the HydraFacial Nation App for consumer engagement.
• Offers Keravive treatment for scalp health.
• Distributes products worldwide through spas and medical practices.

How Does SKIN Make Money?

• Sells HydraFacial systems to spas and medical practices.
• Generates recurring revenue through the sale of proprietary solutions and serums.
• Offers service and maintenance contracts for HydraFacial systems.
• Provides training and support to treatment providers.

What Industry Does SKIN Operate In?

The Beauty Health Company operates within the growing aesthetic technology market, driven by increasing consumer demand for non-invasive cosmetic procedures. The industry is characterized by technological innovation and a focus on personalized treatments. Competitors include companies offering similar aesthetic devices and skincare solutions. The market is expanding globally, with growth opportunities in emerging markets. Beauty Health's success depends on its ability to differentiate its HydraFacial system and related products through technological advancements and effective marketing strategies.

Who Are SKIN's Key Customers?

• Spas and salons offering aesthetic treatments.
• Medical practices specializing in dermatology and cosmetic procedures.
• Individual consumers seeking skin health and aesthetic improvements.

The Beauty Health Company Financial Trajectory

The Beauty Health Company (SKIN) reported $72.1M in revenue for Q2 FY2026, reflecting 11.1% growth compared to the prior quarter. The company recorded a net loss of $2.7M, with diluted EPS of $-0.02. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, SKIN averaged $-0.06 in diluted EPS.

Company Profile

The Beauty Health Company operates in the Medical - Specialties industry within the Healthcare sector. It is headquartered in Long Beach, US. The company is led by CEO Pedro Malha. SKIN has traded publicly since 2020.

How The Beauty Health Company Is Valued

The Beauty Health Company carries a market capitalization of $89.7M, placing it in the micro-cap category. Analyst price targets span from $1.00 to $2.00, with a consensus of $1.50. At the current price of $0.69, that implies approximately 117% upside potential. Relative to its peer group, SKIN's quantitative score of 25/100 is below the peer average of 60/100.

Return on equity for The Beauty Health Company stands at -47.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -5.8%, showing how much profit it generates from its asset base. Its free cash flow yield is 18.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.76 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -31.8%, the inverse of the P/E and a quick read on earnings relative to price.

The Beauty Health Company's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -0.47 places it in the distress zone, a signal of elevated financial risk.

The Beauty Health Company has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 54.8% above estimates on average.

Over the past six months, The Beauty Health Company insiders filed 10 SEC Form 4 transactions — 6 sales and 4 purchases. On net that is roughly 4.6M shares acquired (about $269K) — insiders putting money in tends to read as conviction.

SKIN Financials

SKIN Latest News

SKIN Analyst Consensus

SKIN MoonshotScore

The Beauty Health Company Consumer Defensive Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources